Skip to main content
Clinical Trials/NCT07301398
NCT07301398
Not yet recruiting
Not Applicable

Construction and Preliminary Validation of a Community Health Education Program for Patients With Interstitial Lung Disease Based on Mobile Healthcare

The Fourth Affiliated Hospital of Zhejiang University School of Medicine0 sites92 target enrollmentStarted: December 30, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Enrollment
92
Primary Endpoint
Improve patients' quality of life and reduce medical consumption

Overview

Brief Summary

This study analyzes the needs of patients regarding the content and form of home-based health education through interviews, and constructs a health education program tailored to these needs. A practical WeChat mini-program is developed to enable patients with interstitial lung disease to promptly access comprehensive health education information, consult about follow-up visits, and check test reports during their home care period, ultimately aiming to improve patients' quality of life and reduce medical consumption.

Detailed Description

Interstitial Lung Disease (ILD) refers to a group of non-neoplastic and non-infectious diseases primarily affecting the alveolar walls, including lesions in the perialveolar tissues and adjacent supporting structures. It is characterized by progressive dyspnea, deteriorating lung function, and poor prognosis. In recent years, with the deterioration of air quality, the continuous advancement of diagnosis and treatment technologies, and physicians' deepened understanding of ILD, the diagnosis rate of ILD has been increasing year by year. As the detection rate rises, growing attention is paid to the survival and treatment of ILD patients.

ILD patients often experience labored and rapid breathing, which limits their ability to perform daily activities. Low levels of physical function and vitality, coupled with severe dyspnea and fatigue, lead to a poor quality of life for these patients. Currently, clinical treatments can only control disease progression to a certain extent. Enhancing ILD patients' knowledge of their condition, encouraging active participation of patients and their families in nursing care, and improving patients' ability to monitor and manage their own health can effectively reduce the risk of infections, ensure the clinical efficacy of implemented treatment plans, and further alleviate patients' clinical symptoms.

With societal progress and advances in medical technology, telemedicine has gradually been applied in clinical practice. Telemedicine interventions have proven beneficial for the home-based management and control of chronic diseases such as hypertension and diabetes. Therefore, integrating telemedicine with existing medical and nursing approaches for the home-based health guidance of ILD patients constitutes an innovative research with significant scientific value.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients diagnosed with interstitial lung disease; Aged 18 years or older; Patients who have given informed consent to participate in this study; Proficient in Chinese with no comprehension barriers; Capable of independently using internet-enabled mobile devices.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Improve patients' quality of life and reduce medical consumption

Time Frame: One year after the start of recruitment

Guide doctors and nurses to proficiently use the mini-program to push health education-related knowledge to patients at irregular intervals, and instruct medical staff on the effective collection of questionnaire data and data statistics.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials